title: Sonochemically processed cationic nanocapsules: efficient antimicrobials with membrane disturbing capacity.
abstract: Bacterial-mediated diseases are a major healthcare concern worldwide due to the rapid spread of antibiotic-resistant bacteria. One strategy to manage the bacterial infections while avoiding the emergence of resistant strains implies specific targeting and disruption of bacteria membranes. This work evaluates the potential of nanostructured biopolymer derivatives, nanocapsules (NCs), to disrupt the bacteria cell walls and effectively kill planktonic microorganisms. Two biopolymers, chitosan and cellulose, were chemically modified to synthesize derivatives with improved cationic character (thiolated chitosan and aminocellulose) prior to their processing into nanocapsules via a one-step sonochemical process. The interactions of NCs, displaying an average size of around 250 nm, with bacteria membrane were evaluated using two membrane models: Langmuir monolayers and liposome bilayers composed of a l-α-phosphatidylglycerol phospholipid extracted from Escherichia coli. NCs possessed improved membrane disturbing capacity in comparison to the nonprocessed biopolymer derivatives, by drastically increasing the monolayer fluidity and inducing more than 50% leakage of a dye inserted in the bilayered liposomes. In addition, membrane disturbance was directly proportional to the NCs cationic charge. Whereas evidence showed that thiolated chitosan and aminocellulose interacted with the bacteria membrane through a "carpet model", the NCs were found to induce larger surface defects and high local perturbance through a "detergent model". Importantly, the degree of disruption caused by the biopolymer derivatives and NCs correlated well with the antimicrobial capacity against Escherichia coli, selectively killing bacteria cells without imparting toxicity to human fibroblasts.
authors.affiliation: Grup de Biotecnologia Molecular i Industrial, Department d'Enginyeria Química, Universitat Politècnica de Catalunya , Rambla Sant Nebridi 22, 08222 Terrassa, Spain.
authors.forename: Margarida M
authors.initials: MM
authors.lastname: Fernandes
authors.forename: Antonio
authors.initials: A
authors.lastname: Francesko
authors.forename: Juan
authors.initials: J
authors.lastname: Torrent-Burgués
authors.forename: F Javier
authors.initials: FJ
authors.lastname: Carrión-Fité
authors.forename: Thomas
authors.initials: T
authors.lastname: Heinze
authors.forename: Tzanko
authors.initials: T
authors.lastname: Tzanov
mesh_terms: D000890:Anti-Infective Agents / Q000737:chemistry* / Q000494:pharmacology*; D002412:Cations; D002462:Cell Membrane / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002482:Cellulose / Q000737:chemistry; D048271:Chitosan / Q000737:chemistry; D004353:Drug Evaluation, Preclinical; D004926:Escherichia coli / Q000737:chemistry / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D008051:Lipid Bilayers; D008081:Liposomes / Q000737:chemistry; D053769:Nanocapsules / Q000737:chemistry* / Q000633:toxicity; D036103:Nanotechnology / Q000379:methods; D010715:Phosphatidylglycerols / Q000737:chemistry; D010743:Phospholipids / Q000737:chemistry; D014465:Ultrasonics / Q000379:methods
chemical_list: D000890:Anti-Infective Agents; D002412:Cations; D008051:Lipid Bilayers; D008081:Liposomes; D053769:Nanocapsules; D010715:Phosphatidylglycerols; D010743:Phospholipids; D002482:Cellulose; D048271:Chitosan